We dissected the expression of CD25 on healthy T cells and malignant cells and highlighted that the blood offers a window into the bone marrow composition and could be used to ascertain Treg and CD25+ AML cells prevalence. The gene discussed is IL2RA; the disease is acute myeloid leukemia.